Recently, PRCXI and LEADMUTA have officially signed a strategic cooperation agreement. Zhu Bin, Founder of PRCXI, and Dr. Liu Yusong, Founder and CEO of LEADMUTA, attended the signing ceremony on behalf of both parties.
As technology enterprises deeply engaged in life science automation equipment and AI + robotics technologies respectively, the two companies will carry out in-depth cooperation in the direction of AI for Science, and jointly build a full-process unmanned intelligent laboratory.
Core of the Cooperation:
Integrating All Links to Achieve Unmanned Operation Throughout the Entire Experimental Chain
Life science experiments involve long processes, numerous steps and intensive repetitive tasks. Traditional automation has mostly been limited to point-based substitution—where only single operations such as pipetting and aliquoting are replaced by machines, while sample transfer, data collection and equipment coordination still rely heavily on manual intervention. The collaboration between PRCXI and LEADMUTA aims to break this bottleneck.
PRCXI provides automated hardware and software solutions covering full scenarios in life sciences. It boasts a mature product portfolio and extensive on-the-ground implementation experience across genomics, smart agriculture, synthetic biology, proteomics, pathogenic microbiology, biochips and other fields.
PRCXI Core Products: Comprehensive Solutions from Standalone Instruments to Integrated Hardware, Software and Consumables
Single-module Automation：Automates and intelligently upgrades a single operation or procedure in the laboratory.
Workstation Automation: Integrates multiple modules for commonly used workflows to achieve continuous automation.
Line Automation: Designed for high-volume samples, integrating various sample pre-treatment processes to realize full-process automation.
Intelligent Automation: Enables self-learning, adaptive adjustment, and intelligent decision-making for laboratory automation systems.
General-Purpose Instruments: Adaptable to standardized experimental operations across multiple fields.
Medical Consumables: Focuses on disposable biotech and medical consumables for laboratory automation and high-throughput applications.
LEADMUTA contributes its strengths in AI algorithms and robotics technologies, with leading capabilities in embodied intelligence and autonomous execution.
The two parties will use AI as the brain, and automation equipment and robots as the hands and limbs, to truly connect every step in the experimental workflow.
From sample processing, pipetting and aliquoting, to experiment execution, data collection and analysis, a closed-loop, unmanned and intelligent full-process operation will be realized.
Future Outlook
Strategic Collaboration for Intelligent Life Science Laboratories
This strategic cooperation marks a pivotal partnership between intelligent laboratory robotic systems and laboratory automation equipment. The two parties will promote implementation across three dimensions:
Equipment Integration
PRCXI’s high-precision liquid handling equipment will be seamlessly connected with LEADMUTA’s laboratory robots, enabling fully automated operation covering liquid handling, sample transportation and experimental procedures.
Solution Co-Development
Through collaborative R&D, joint testing and combined delivery of integrated hardware and software solutions, the partners will provide mature and stable intelligent laboratory overall solutions for scientific research, medical treatment, testing, pharmaceuticals and other industries.
Market Expansion
The two sides will share channels, coordinate projects and conduct joint brand promotion to jointly explore the market for laboratory automation upgrades.
About Prcxi
Since its founding in 2014, PRCXI has been deeply engaged in the field of life science laboratory automation, focusing on the R&D and manufacturing of laboratory automation systems and consumables. Rooted in the independent innovation of underlying core technologies and supported by intelligent manufacturing collaboration across the entire industrial chain, the company upholds its mission as a "Popularizer of Life Science Automation".
Different from the traditional integrator model,PRCXI firmly takes a technology-driven development path of "AI + Automation Equipment + Full Independent Manufacturing". With its proprietary AI model as the intelligent core, the company achieves closed-loop production covering the entire chain from core component R&D and precision machining to complete machine assembly.
At present, PRCXI has established R&D and manufacturing bases in Suzhou, Nanjing, Xiangyang and Guangzhou. Its products cover more than a dozen cutting-edge fields including molecular breeding, biopharmaceuticals and in vitro diagnostics, with over 100 application scenarios deployed in laboratories.
AboutLEADMUTA
Founded in 2021, LEADMUTA is a pioneering enterprise in the field of AI for Science autonomous agents in China. It was jointly established by a PhD team from Zhejiang University and high-level overseas returnees.
The company focuses on the R&D and industrial application of AI + robotics technologies, and is committed to providing customers with one-stop intelligent solutions including AI for Science smart laboratories, fully automated "lights-out factories" for semiconductors and electronic manufacturing.
Recently, LEADMUTA has served many Fortune Global 500 companies and listed enterprises at home and abroad, including Micron, SK Hynix, Wistron, ASE Group and Foxconn.
In March this year, the company completed an A+ round financing of over 100 million RMB, which will be mainly used for the construction of its intelligent robotics manufacturing base, R&D of embodied intelligence algorithms, and expansion of its core talent team.
